IMNX: Immunex Corporation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNX: Immunex Corporation

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rich23241 who wrote (2)	12/17/2001 12:23:00 AM
From: Dave Gore	Read Replies (1) of 6

Hi Rich, I am on top of this one. It looks like it really might happen and it will be controversial no matter how it comes out. While IMNX sports a rather high PE compared to AMGN, if AMGN can greatly help them expand their production of Enbrel sooner, then AMGN is getting a good bargain at $30-31 per share. Talks are continuing Sunday night with AHP really anxious to make it work as well to get much needed cash. If so, they may be willing to give up some of their marketing rights to Enbrel overseas which is something IMNX did not benefit from. As always it will be interesting to watch. I was kind of hoping to see a $35 bid for IMNX, but doesn't look like it will be much, if any, over $30/sh. -Dave

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next